Editorial / 07
About Wolverine Meds
A records desk for the published BPC-157 TB-500 record — what each peptide is, what its literature shows, and how the access picture actually stands.
What this site is
Wolverine Meds keeps a records desk on the BPC-157 TB-500 blend and its two constituent peptides, drawn from the peer-reviewed literature. There is no clinic here and no clinician on staff; the pages diagnose no one and advise no one. Nothing is made, sold, or shipped from this address. The work is reading published science and filing each finding under the study that recorded it.
We built the site as a console rather than a brochure because the subject demands it. "Wolverine" is not one drug — it is two peptides on two different channels, BPC-157 on the angiogenic and cytoprotective route and TB-500 on the actin-migration route. Reading them channel by channel is the only honest way to summarize a blend whose combination has never been studied in a controlled trial.
What 'meds' means here, and what it does not
The word "meds" in our domain is a label about subject, not a claim about our services. It signals the question this site exists to answer: what is this blend studied for, and how does medicinal and compounding access actually work for it? It does not mean we are a pharmacy, a telehealth provider, or a dispensary. We hold no inventory, fill no prescriptions, and recommend no protocols.
That distinction runs through everything here. Where the literature is precise — a sequence, a crystallography result, a rat dose — we state it precisely. Where it is thin — no controlled blend trial, no validated human pharmacokinetics — we say so plainly and flag the gap. The regulatory page is built strictly from primary FDA sources and presents the current 503A status as fact while treating the scheduled 2026 advisory-committee review as exactly what it is: a step in evaluation, not an outcome.
How we cite
Every quantitative claim on this site — every dose, sequence, molecular weight, and effect — maps to a numbered citation that resolves to a DOI, a PubMed identifier, or an authoritative FDA URL. We do not paraphrase findings we cannot point to. When a claim is a community belief rather than a published result, we label it as such. The full citation list lives on the references page, and inline markers throughout the site open the underlying source on hover.